TrialClinical pharmacokinetics2019

Bayesian Population Model of the Pharmacokinetics of Venetoclax in Combination with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from the Phase III MURANO Study.

Rong Deng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.